Testing cancer drugs using patient-derived organoid models

PREDICTIVE DRUG TESTING IN ORGANOID MODELS

NIH-funded research Leidos Biomedical Research, INC. · NIH-10281352

This study is looking at how well different cancer drugs work by testing them on tiny models made from real patient tumors, so we can find out which treatments might be best for you based on your unique cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLeidos Biomedical Research, INC. NIH-funded
Lab location1 site (Frederick, United States)
Project IDNIH-10281352 on NIH RePORTER

What this research studies

This research investigates how effective various cancer drugs are by using organoid models created from actual patient tumor tissues. By employing high-throughput screening techniques, the study aims to identify which tumors respond to specific drugs and to understand the mechanisms behind these responses. Additionally, it will explore predictive biomarkers that indicate how well a patient might respond to treatment, as well as the impact of genetic changes on drug effectiveness. This approach allows for a more personalized treatment strategy for cancer patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients with tumors that can be used to create organoid models, particularly those with specific genetic alterations.

Not a fit: Patients without tumors or those whose tumors cannot be cultured into organoids may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments for patients.

How similar studies have performed: Other research has shown promise in using organoid models for drug testing, indicating that this approach could be effective.

Where this research is happening

Frederick, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer AgentsCancer DrugNeoplastic Disease Chemotherapeutic Agentsanti-cancer druganticancer agent
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.